VERU INC. Operating Cash Flow
VERU INC. (VERU) reported Operating Cash Flow of -$20.55 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-10
- VERU INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$5.47M.
- VERU INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$8.91M.
- VERU INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.17M.
- VERU INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$5.49M.
- VERU INC. net cash provided by (used in) operating activities for fiscal 2025 was -$30.04M.
- VERU INC. net cash provided by (used in) operating activities for fiscal 2024 was -$21.68M.
- VERU INC. net cash provided by (used in) operating activities for fiscal 2023 was -$88.01M.
- VERU INC. net cash provided by (used in) operating activities for fiscal 2022 was -$47.51M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$5.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | -$14.38M derived: sum of 2 quarters · filed 2026-08-10 | -$20.55M 10-Q · filed 2026-08-10 | -$26.04M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$8.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | -$15.08M 10-Q · filed 2026-05-13 | -$20.58M derived: sum of 3 quarters · filed 2026-05-13 | -$26.06M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$6.17M 10-Q · filed 2026-02-11 | -$11.66M derived: sum of 2 quarters · filed 2026-02-11 | -$17.14M derived: sum of 3 quarters · filed 2026-08-10 | -$24.88M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-09-30 | -$5.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | -$10.97M derived: sum of 2 quarters · filed 2026-08-10 | -$18.71M derived: sum of 3 quarters · filed 2026-08-10 | -$30.04M 10-K · filed 2025-12-17 |
| 2025-06-30 | -$5.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | -$13.22M derived: sum of 2 quarters · filed 2026-08-10 | -$24.55M 10-Q · filed 2026-08-10 | -$28.92M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | -$7.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | -$19.07M 10-Q · filed 2026-05-13 | -$23.44M derived: sum of 3 quarters · filed 2026-05-13 | -$29.08M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$11.33M 10-Q · filed 2026-02-11 | -$15.70M derived: sum of 2 quarters · filed 2026-02-11 | -$21.34M derived: sum of 3 quarters · filed 2026-02-11 | -$26.99M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | -$4.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | -$10.01M derived: sum of 2 quarters · filed 2025-12-17 | -$15.66M derived: sum of 3 quarters · filed 2025-12-17 | -$21.68M 10-K · filed 2025-12-17 |
| 2024-06-30 | -$5.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | -$11.30M derived: sum of 2 quarters · filed 2025-08-12 | -$17.32M 10-Q · filed 2025-08-12 | -$26.81M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$5.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-08 | -$11.67M 10-Q · filed 2025-05-08 | -$21.16M derived: sum of 3 quarters · filed 2025-05-08 | -$39.59M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$6.02M 10-Q · filed 2025-02-13 | -$15.51M derived: sum of 2 quarters · filed 2025-02-13 | -$33.94M derived: sum of 3 quarters · filed 2025-02-13 | -$59.50M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | -$9.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-16 | -$27.92M derived: sum of 2 quarters · filed 2024-12-16 | -$53.48M derived: sum of 3 quarters · filed 2024-12-16 | -$88.01M 10-K · filed 2024-12-16 |
| 2023-06-30 | -$18.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | -$43.99M derived: sum of 2 quarters · filed 2024-08-08 | -$78.52M 10-Q · filed 2024-08-08 | -$99.40M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$25.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | -$60.09M 10-Q · filed 2024-05-08 | -$80.97M derived: sum of 3 quarters · filed 2024-05-08 | -$94.99M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$34.53M 10-Q · filed 2024-04-01 | -$55.41M derived: sum of 2 quarters · filed 2024-04-01 | -$69.43M derived: sum of 3 quarters · filed 2024-04-01 | -$73.38M derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-09-30 | -$20.88M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | -$34.90M derived: sum of 2 quarters · filed 2024-04-01 | -$38.85M derived: sum of 3 quarters · filed 2024-04-01 | -$47.51M 10-K/A · filed 2024-04-01 |
| 2022-06-30 | -$14.02M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-11-15 | -$17.97M derived: sum of 2 quarters · filed 2023-11-15 | -$26.63M 10-Q/A · filed 2023-11-15 | -$27.43M derived: sum of 4 quarters · filed 2023-11-15 |
| 2022-03-31 | -$3.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | -$12.60M 10-Q · filed 2023-05-11 | -$13.41M derived: sum of 3 quarters · filed 2023-05-11 | -$26.25M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$8.66M 10-Q · filed 2023-02-09 | -$9.46M derived: sum of 2 quarters · filed 2023-02-09 | -$22.30M derived: sum of 3 quarters · filed 2023-02-09 | -$24.89M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | -$806.47K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | -$13.64M derived: sum of 2 quarters · filed 2022-12-05 | -$16.23M derived: sum of 3 quarters · filed 2022-12-05 | -$15.57M 10-K · filed 2022-12-05 |
| 2021-06-30 | -$12.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | -$15.42M derived: sum of 2 quarters · filed 2022-08-11 | -$14.76M 10-Q · filed 2022-08-11 | -$15.11M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$2.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | -$1.93M 10-Q · filed 2022-05-12 | -$2.27M derived: sum of 3 quarters · filed 2022-05-12 | $1.07M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $659.24K 10-Q · filed 2022-02-09 | $318.13K derived: sum of 2 quarters · filed 2022-02-09 | $3.66M derived: sum of 3 quarters · filed 2022-02-09 | $1.24M derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-09-30 | -$341.11K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | $3.00M derived: sum of 2 quarters · filed 2021-12-02 | $580.41K derived: sum of 3 quarters · filed 2021-12-02 | -$1.93M 10-K · filed 2021-12-02 |
| 2020-06-30 | $3.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $921.52K derived: sum of 2 quarters · filed 2021-08-12 | -$1.59M 10-Q · filed 2021-08-12 | -$2.54M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-12 | -$4.93M 10-Q · filed 2021-05-12 | -$5.88M derived: sum of 3 quarters · filed 2021-05-12 | -$6.41M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$2.51M 10-Q · filed 2021-02-10 | -$3.47M derived: sum of 2 quarters · filed 2021-02-10 | -$3.99M derived: sum of 3 quarters · filed 2021-02-10 | -$6.49M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-09-30 | -$955.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | -$1.48M derived: sum of 2 quarters · filed 2020-12-10 | -$3.98M derived: sum of 3 quarters · filed 2020-12-10 | -$5.49M 10-K · filed 2020-12-10 |
| 2019-06-30 | -$527.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-13 | -$3.02M derived: sum of 2 quarters · filed 2020-08-13 | -$4.53M 10-Q · filed 2020-08-13 | -$7.35M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-13 | -$4.00M 10-Q · filed 2020-05-13 | -$6.82M derived: sum of 3 quarters · filed 2020-05-13 | -$11.37M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | -$1.51M 10-Q · filed 2020-02-12 | -$4.32M derived: sum of 2 quarters · filed 2020-02-12 | -$8.87M derived: sum of 3 quarters · filed 2020-02-12 | -$13.35M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-09-30 | -$2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | -$7.36M derived: sum of 2 quarters · filed 2019-12-12 | -$11.84M derived: sum of 3 quarters · filed 2019-12-12 | -$11.55M 10-K · filed 2019-12-12 |
| 2018-06-30 | -$4.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-08 | -$9.03M derived: sum of 2 quarters · filed 2019-08-08 | -$8.73M 10-Q · filed 2019-08-08 | -$8.15M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | -$4.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | -$4.18M 10-Q · filed 2019-05-15 | -$3.61M derived: sum of 3 quarters · filed 2019-05-15 | -$2.14M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $296.66K 10-Q · filed 2019-02-13 | $874.08K derived: sum of 2 quarters · filed 2019-02-13 | $2.34M derived: sum of 3 quarters · filed 2019-02-13 | $113.58K derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-09-30 | $577.42K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | $2.04M derived: sum of 2 quarters · filed 2018-12-13 | -$183.08K derived: sum of 3 quarters · filed 2018-12-13 | $982.89K 10-K · filed 2018-12-13 |
| 2017-06-30 | $1.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | -$760.49K derived: sum of 2 quarters · filed 2018-08-14 | $405.47K 10-Q · filed 2018-08-14 | |
| 2017-03-31 | -$2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | -$1.06M 10-Q · filed 2018-05-11 | ||
| 2016-12-31 | $1.17M 10-Q · filed 2018-02-14 | |||
| 2014-03-31 | -$15.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-01 | $1.17M 10-Q · filed 2014-05-01 | $202.26K derived: sum of 3 quarters · filed 2014-05-01 | $7.97M derived: sum of 4 quarters · filed 2014-05-01 |
| 2013-12-31 | $1.18M 10-Q · filed 2014-02-03 | $218.04K derived: sum of 2 quarters · filed 2014-02-03 | $7.98M derived: sum of 3 quarters · filed 2014-02-03 | $11.96M derived: sum of 4 quarters · filed 2014-05-01 |
| 2013-09-30 | -$963.62K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $6.80M derived: sum of 2 quarters · filed 2013-12-03 | $10.78M derived: sum of 3 quarters · filed 2014-05-01 | $11.79M 10-K · filed 2013-12-03 |
| 2013-06-30 | $7.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-01 | $11.74M derived: sum of 2 quarters · filed 2014-05-01 | $12.76M 10-Q · filed 2013-08-01 | $14.08M derived: sum of 4 quarters · filed 2014-05-01 |
| 2013-03-31 | $3.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-01 | $4.99M 10-Q · filed 2014-05-01 | $6.32M derived: sum of 3 quarters · filed 2014-05-01 | $10.30M derived: sum of 4 quarters · filed 2014-05-01 |
| 2012-12-31 | $1.02M 10-Q · filed 2014-02-03 | $2.34M derived: sum of 2 quarters · filed 2014-02-03 | $6.32M derived: sum of 3 quarters · filed 2014-02-03 | $9.51M derived: sum of 4 quarters · filed 2014-02-03 |
| 2012-09-30 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $5.30M derived: sum of 2 quarters · filed 2013-12-03 | $8.49M derived: sum of 3 quarters · filed 2013-12-03 | $10.36M 10-K · filed 2013-12-03 |
| 2012-06-30 | $3.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-01 | $7.17M derived: sum of 2 quarters · filed 2013-08-01 | $9.03M 10-Q · filed 2013-08-01 | $11.39M derived: sum of 4 quarters · filed 2013-12-03 |
| 2012-03-31 | $3.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-02 | $5.05M 10-Q · filed 2013-05-02 | $7.41M derived: sum of 3 quarters · filed 2013-12-03 | $9.48M derived: sum of 4 quarters · filed 2013-12-03 |
| 2011-12-31 | $1.86M 10-Q · filed 2013-01-30 | $4.22M derived: sum of 2 quarters · filed 2013-12-03 | $6.29M derived: sum of 3 quarters · filed 2013-12-03 | $6.72M derived: sum of 4 quarters · filed 2013-12-03 |
| 2011-09-30 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-03 | $4.43M derived: sum of 2 quarters · filed 2013-12-03 | $4.86M derived: sum of 3 quarters · filed 2013-12-03 | $6.97M 10-K · filed 2013-12-03 |
| 2011-06-30 | $2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-07-31 | $2.50M derived: sum of 2 quarters · filed 2012-07-31 | $4.61M 10-Q · filed 2012-07-31 | $5.21M derived: sum of 4 quarters · filed 2012-12-04 |
| 2011-03-31 | $431.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-01 | $2.54M 10-Q · filed 2012-05-01 | $3.13M derived: sum of 3 quarters · filed 2012-12-04 | |
| 2010-12-31 | $2.11M 10-Q · filed 2012-01-31 | $2.70M derived: sum of 2 quarters · filed 2012-12-04 | ||
| 2010-09-30 | $594.57K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-04 | $3.99M 10-K · filed 2012-12-04 | ||
| 2010-06-30 | $3.40M 10-Q · filed 2011-08-05 | |||
| 2009-09-30 | $5.75M 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |